StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) income statement

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30104% above fair value
$3.80−0.01 (-0.26%)

Close on Nov 20, 2026Market cap $1.33BP/E –Yield –

See a number that looks wrong?